Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

US Patent 11174306 · Granted Nov 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Binding molecules with modified J-chain2025
CD25 antibodies2025
Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using 2025
Anti-TREM2 antibodies and related methods2025
Anti-MARCO antibodies and uses thereof2025
Single-chain TNF Receptor 2 agonist fusion proteins2025
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions 2025
Long-acting dual GIP/GLP-1 peptide conjugates and methods of use2025
Anti-PVRIG antibodies and methods of use2025
Nucleic acids encoding, and methods of producing, antibodies that bind human che2025
Relaxin immunoglobulin fusion proteins and methods of use2025